Inventor · disambiguated record
Steven L. Krill
Also filed as: KRILL STEVEN L
19 granted patents·21 pending applications·451 citations·filing 1998–2025
93Inventor score
Top patents by PatentIndex Score
40 records- 0198US7374779B2Pharmaceutical formulations and systems for improved absorption and multistage release of active agentsLIPOCINE INC·Filed 2002·Granted May 20, 2008·332 cites·86 claims
- 0297US11207334B1Fospropofol formulationsEPALEX CORP·Filed 2021·Granted Dec 28, 2021·9 cites·21 claims
- 0395US11478490B1Fospropofol formulationsEPALEX CORP·Filed 2021·Granted Oct 25, 2022·3 cites·16 claims
- 0494US11439653B1Fospropofol formulationsEPALEX CORP·Filed 2021·Granted Sep 13, 2022·2 cites·7 claims
- 0592US11628178B2Fospropofol methods and compositionsEPALEX CORP·Filed 2022·Granted Apr 18, 2023·6 cites·32 claims
- 0689US12115164B2Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Granted Oct 15, 2024·0 cites·15 claims
- 0789US11547714B2Fospropofol salts, methods and compositionsEPALEX CORP·Filed 2021·Granted Jan 10, 2023·2 cites·2 claims
- 0888US2023414623A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0988US2023390295A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1086US7364752B1Solid dispersion pharamaceutical formulationsABBOTT LAB·Filed 2000·Granted Apr 29, 2008·23 cites·10 claims
- 1184US11793813B2Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Granted Oct 24, 2023·0 cites·9 claims
- 1284US2023000874A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1384US2022409623A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1484US2022409624A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1581US11590077B2Fulvestrant formulations and methods of their useEAGLE PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·2 cites·56 claims
- 1676US12397006B2Fospropofol formulationsEPALEX CORP·Filed 2022·Granted Aug 26, 2025·0 cites·18 claims
- 1776US2019201405A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1875US2024245626A1Propofol compositions and methods of useEPALEX CORP·Filed 2024·Application pending·0 cites
- 1973US2025312361A1Fospropofol methods and compositionsEPALEX CORP·Filed 2025·Application pending·0 cites
- 2072US6033685ATablet for the controlled release of active agentsABBOTT LAB·Filed 1998·Granted Mar 7, 2000·42 cites·19 claims
- 2172US2018289710A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2271US12377110B2Fospropofol methods and compositionsEPALEX CORP·Filed 2023·Granted Aug 5, 2025·0 cites·32 claims
- 2371US12364704B2Fospropofol salts, methods and compositionsEPALEX CORP·Filed 2022·Granted Jul 22, 2025·0 cites·3 claims
- 2471US6465011B2Formulations comprising lipid-regulating agentsABBOTT LAB·Filed 1999·Granted Oct 15, 2002·30 cites·9 claims
- 2570US2023083749A1Propofol compositions and methods of useEPALEX CORP·Filed 2022·Application pending·0 cites
- 2670US2023091857A1Fospropofol formulationsEPALEX CORP·Filed 2022·Application pending·0 cites
- 2767US2017239250A1Pemetrexed formulationsEAGLE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2866US12370199B2Fulvestrant formulations and methods of their useEAGLE PHARMACEUTICALS INC·Filed 2021·Granted Jul 29, 2025·0 cites·5 claims
- 2965US2022313711A1Fospropofol formulationsEPALEX CORP·Filed 2021·Application pending·0 cites
- 3063US2023084521A1Propofol prodrug methods and compositionsEPALEX CORP·Filed 2022·Application pending·0 cites
- 3162US12186427B2Fulvestrant formulations and methods of their useEAGLE PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·18 claims
- 3258US9107830B2Inhibitors of crystallization in a solid dispersionFORT JAMES J·Filed 2007·Granted Aug 18, 2015·0 cites·14 claims
- 3355US2022105050A1Propofol prodrug methods and compositionsEPALEX CORP·Filed 2020·Application pending·0 cites
- 3455US2019134059A1Fulvestrant formulations and methods of their useEAGLE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3553US2016106840A1Aqueous buffer-free bivalirudin compositionsEAGLE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3651US2015328317A1Aqueous buffer-free bivalirudin compositionsEAGLE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3750US2003104048A1Pharmaceutical dosage forms for highly hydrophilic materialsLIPOCINE INC·Filed 2002·Application pending·0 cites
- 3842US2022105111A1Fospropofol methods and compositionsEPALEX CORP·Filed 2020·Application pending·0 cites
- 3940US8486447B2Pharmaceutical formulationABU SHMEIS RAMA ALI·Filed 2004·Granted Jul 16, 2013·0 cites·5 claims
- 4033US2010179182A1Pharmaceutical formulationSHMEIS RAMA ALI ABU·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven L. Krill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →